news.cmlviz.com
menu
share

Teva Pharmaceutical Industries Limited versus Zoetis Inc Head to Head Compare


Date Published:

This is a head to head compare of Teva Pharmaceutical Industries Limited (NYSE:TEVA) and Zoetis Inc (NYSE:ZTS) . We will compare the two companies on revenue growth, earnings, revenue per employee, operating margins, free cash flow and valuation. The head to head compare assigns 100 points in total.



Before we dive into the analysis, we will look at the stock returns for each company over the last three months, six months and the last year. The stock returns do not impact the head to head compare scores which are focused on the fundamentals of each company, but ultimately stock returns are are still a critical piece to a full analysis and compare.


Stock Returns
Symbol 3-Months 6-Months One-Year Fundamentals
TEVA -6.8% -29.6% -45.9%
ZTS +0.3% +6.2% +11.7%

Zoetis Inc has a higher fundamental rating then Teva Pharmaceutical Industries Limited which has an impact on the head-to-head comparison. The CML Star Rating is an objective, quantifiable measure of a company's operating and financial condition. The rating is computed by measuring numerous elements of the company's current financial data and their associated changes over time.

Now, let's dive into the two companies to compare them.

➤ Income Statement
First we turn to the income statement and compare revenue, earnings and revenue per employee for both companies. We note that simple revenue comparisons do not impact the rating.

Teva Pharmaceutical Industries Limited has substantially higher revenue in the last year than Zoetis Inc. Raw revenue comps do not affect the head to head rating.
Revenue

Both TEVA and ZTS show positive earnings over the last year with the edge to ZTS.

Net Income


ZTS generates notably larger revenue per employee ($543,000) than TEVA ($385,000).

Revenue per Employee
($ Millions)


➤ Margins
Next we create some derived metrics to compare the the amount of revenue earned per dollar of expense and the amount of free cash flow earned per dollar of revenue. Margins are one of the fairest ways to compare companies since they remove some of the bias of large versus small numbers.

Teva Pharmaceutical Industries Limited generates $1.48 in revenue for every $1 of expense, very similar to Zoetis Inc's $1.37.

Revenue per Dollar of Expense


TEVA generates $0.18 in levered free cash flow for every $1 of revenue, notably higher than ZTS's $0.13.

Free Cash Flow
per Dollar of Revenue


➤ Growth
Finally we compare the financial metrics related to growth: revenue growth rates and price to sales.

Both companies are growing revenue. Teva Pharmaceutical Industries Limited is growing revenue massively faster than Zoetis Inc.

Revenue Growth


For every $1 in revenue, the stock market prices in $1.70 in market cap for TEVA and $5.38 in market cap for ZTS.

Price to Sales

Zoetis Inc (NYSE:ZTS)
defeats
Teva Pharmaceutical Industries Limited (NYSE:TEVA) : 52 to 48